Tata is likely to join hands with Moderna to launch Covid-19 vaccine in India

Tata is likely to join hands with Moderna to launch Covid-19 vaccine in India

1 min


103
18 shares, 103 points

Tata Group’s healthcare venture is said to have started initial discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India, the Economic Times reported on Monday.

Tata Medical & Diagnostics could team up with the India’s Council of Scientific and Industrial Research to carry out clinical trials of Moderna’s vaccine candidate in India, the said, citing officials familiar with the matter.

Tata is likely to join hands with the Council of Scientific & Industrial Research (CSIR)—India’s premier research organization—to conduct clinical trials of Moderna’s vaccine candidate in India.

It is worth mentioning here that foreign vaccine makers must carry out a bridging trial on the Indian population in the country before rolling out their products. More importantly, if the vaccines are approved abroad, foreign companies must conduct phase-3 trials with volunteers in India.

In January 2020, the Coalition for Epidemic Preparedness Innovations (CEPI)—a part of the COVAX facility of the World Health Organization—provided funds to Moderna to develop its mRNA vaccine against the coronavirus. Plus, the COVAX facility wants to equitably distribute 200 crore Covid-19 vaccines in low-and middle-income countries including India by the end of 2021.


Like it? Share with your friends!

103
18 shares, 103 points

What's Your Reaction?

hate hate
7
hate
confused confused
21
confused
fail fail
14
fail
fun fun
11
fun
geeky geeky
9
geeky
love love
2
love
lol lol
4
lol
omg omg
21
omg
win win
14
win

0 Comments

Your email address will not be published. Required fields are marked *